Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01225991 · ClinicalTrials.gov registry record · Phase 4

Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis

A Phase 4 study of Rheumatoid Arthritis, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 4
Development phase
18
Enrollment target
1
Study location

NCT01225991 is a Phase 4 study of Rheumatoid Arthritis that has completed, run by University of California, Los Angeles. The registered enrollment target is 18 participants, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01225991, a Phase 4 study of Rheumatoid Arthritis, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 4
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the effects of milnacipran for the treatment of pain in rheumatoid arthritis in older adults.

Conditions Studied

Rheumatoid Arthritis

Interventions

  • DRUG Milnacipran

Study Locations (1)

California

  • UCLA Semel Institute - Los Angeles

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2010-11
Est. Completion 2013-06
Phase Phase 4

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01225991

The ClinicalTrials.gov registry entry for NCT01225991 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Milnacipran is the first listed.

NCT01225991 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01225991 about?

NCT01225991 is a clinical study titled "Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis". The purpose of this study is to examine the effects of milnacipran for the treatment of pain in rheumatoid arthritis in older adults.

What is the current status of trial NCT01225991?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2010-11. Estimated completion is 2013-06.

What conditions does trial NCT01225991 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT01225991?

The interventions under investigation include: Milnacipran (DRUG).

Who is sponsoring clinical trial NCT01225991?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01225991 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.